Bank Of Montreal Bei Gene, Ltd. Transaction History

Bank Of Montreal

$192 Billion
Q1 2025

A detailed history of Bank Of Montreal transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Bank Of Montreal holds 7,976 shares of BGNE stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,976

Previous 7,901 0.95%

Holding current value

$1.81 Million

Previous $1.46 Million 23.92%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$175.1 - $226.71 $13,132 - $17,003	75 Added 0.95%	7,976 $1.81 Million
Q4 2024 Feb 13, 2025	SELL	$174.72 - $246.04 $57,308 - $80,701	-328 Reduced 3.99%	7,901 $1.46 Million
Q3 2024 Nov 13, 2024	SELL	$143.93 - $224.51 $259,361 - $404,567	-1,802 Reduced 17.96%	8,229 $1.85 Million
Q2 2024 Aug 14, 2024	BUY	$129.52 - $174.32 $1,942 - $2,614	15 Added 0.15%	10,031 $1.43 Million
Q1 2024 May 13, 2024	BUY	$141.8 - $181.47 $260,628 - $333,541	1,838 Added 22.47%	10,016 $1.57 Million
Q4 2023 Feb 08, 2024	SELL	$158.67 - $201.58 $103,928 - $132,034	-655 Reduced 7.42%	8,178 $1.47 Million
Q3 2023 Nov 01, 2023	SELL	$179.87 - $225.13 $645,193 - $807,541	-3,587 Reduced 28.88%	8,833 $1.59 Million
Q2 2023 Aug 02, 2023	SELL	$178.3 - $266.78 $110,546 - $165,403	-620 Reduced 4.75%	12,420 $2.21 Million
Q1 2023 Jun 13, 2024	BUY	$215.53 - $274.5 $689,049 - $877,576	3,197 Added 31.92%	13,213 $2.85 Million
Q4 2022 Feb 01, 2023	SELL	$125.51 - $229.3 $5.45 Million - $9.96 Million	-43,435 Reduced 76.91%	13,040 $2.87 Million
Q3 2022 Nov 10, 2022	SELL	$131.8 - $202.24 $3.11 Million - $4.77 Million	-23,587 Reduced 29.46%	56,475 $7.98 Million
Q2 2022 Aug 11, 2022	BUY	$121.11 - $216.05 $7.93 Million - $14.1 Million	65,491 Added 449.46%	80,062 $13.7 Million
Q1 2022 May 12, 2022	BUY	$146.52 - $269.56 $351,061 - $645,865	2,396 Added 19.68%	14,571 $3 Million
Q4 2021 Feb 11, 2022	SELL	$248.56 - $389.34 $2.59 Million - $4.05 Million	-10,406 Reduced 46.08%	12,175 $3.37 Million
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $653,203 - $1.06 Million	2,617 Added 13.11%	22,581 $8.23 Million
Q2 2021 Aug 12, 2021	BUY	$292.75 - $367.01 $5.84 Million - $7.33 Million	19,964 New	19,964 $7.25 Million

Others Institutions Holding BGNE

# of Institutions

295

Shares Held

40.1M

Call Options Held

111K

Put Options Held

114K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account